Jounce stock price
Nettet12. apr. 2024 · According to analysts' consensus price target of $6.00, Jounce Therapeutics has a forecasted upside of 298.7% from its current price of $1.51. … Nettet15. mar. 2024 · News Jounce Therapeutics Inc. Significant News Only No significant news for JNCE in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.99 Market Cap $96.46 M Shares...
Jounce stock price
Did you know?
Nettet5. apr. 2024 · Jounce Therapeutics (JNCE) Stock Price & Analysis 302 Followers JNCE Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $0.58 - $7.94 Previous Close $1.85 Volume 5.37M Average Volume (3M) 2.75M Market Cap $96.46M Enterprise Value $96.46M Total Cash (Recent Filing) $0.00 Total Debt (Recent Filing) … Nettet13. apr. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 1.07% to the previous day’s close as …
NettetShareholders have faith in loss-making Jounce Therapeutics (NASDAQ:JNCE) as stock climbs 12% in past week, taking three-year gain to 95% Simply Wall St. Nov-04-21 … NettetUse our historic performance chart to see real-time Jounce Therapeutics Inc stock price and the Jounce Therapeutics Inc news feed to help further your research before investing in fractional shares with any dollar amount you choose. 2. Choose a Stash plan and set up your investment account in just a few minutes.
Nettet10. apr. 2024 · Jounce Therapeutics NasdaqGS:JNCE Stock Report Last Price US$1.85 Market Cap US$96.8m 7D 22.5% 1Y -74.1% Updated 02 Apr, 2024 Data Company … Nettet15. mar. 2024 · View the latest Jounce Therapeutics Inc. (JNCE) stock price, news, historical charts, analyst ratings and financial information from WSJ. JNCE Jounce …
Nettet13. apr. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 1.07% to the previous day’s close as strong demand from buyers drove the stock to $1.89. Actively observing the price movement in the last trading, the stock closed the session at $1.87, falling within a …
Nettet4. apr. 2024 · JOUNCE THERAPEUTICS, INC. : JNCE Stock Price US4811161011 MarketScreener Homepage Equities United States Nasdaq Jounce Therapeutics, Inc. … cynthias ambition rainbow cardNettet9. apr. 2024 · The stock was sold at an average price of $1.10, for a total transaction of $22,210.10. Jounce Therapeutics Stock Down 0.5 % NASDAQ:JNCE opened at $1.89 on Friday. biltmore theater asheville ncNettetJounce Therapeutics Inc (JNCE) Stock Price Today, News, Quotes, FAQs and Fundamentals More Advertisement 3rd Party Ad. Not an offer or recommendation by … cynthia samson 66Nettet27. mar. 2024 · JOUNCE THERAPEUTICS, INC. (Name of Person (s) Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 481116101 (CUSIP Number of Common Stock) Jacquelyn... biltmore theatreNettet18. mar. 2024 · Jounce Therapeutics stock was originally listed at a price of $17.25 in Jan 27, 2024. If you had invested in Jounce Therapeutics stock at $17.25, your return over … biltmore thanksgiving packageNettet10. apr. 2024 · Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating account. Shares of Jounce Therapeutics Inc. JNCE, -6.09% … biltmore theater ashevilleNettetJounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T ... cynthia sanborn norfolk southern